Search clinical trials for: Thienopyridine

Total 33 results

University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS)

Peptic Ulcer Hemorrhage | Upper Gastrointestinal Bleeding | Anticoagulant-induced Bleeding

United States
W.L.Gore & Associates

Active, not recruiting

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study (RELIEF)

Migraine | Patent Foramen Ovale | PFO - Patent Foramen Ovale

United States
Scripps Health
Bristol-Myers Squibb; Sanofi; Accumetrics, Inc.

Completed

Genotype Information and Functional Testing Study (GIFT)

Coronary Artery Disease

United States
VA Office of Research and Development

Completed

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA)

Saphenous Vein Graft Atherosclerosis

United States
Daiichi Sankyo, Inc.

Completed

Prasugrel/Clopidogrel Maintenance Dose Washout Study

Coronary Artery Disease

United States
Medstar Health Research Institute

Completed

Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting (Serial CABG)

Complication of Coronary Artery Bypass Graft | Peri-operative Hemorrhage or Hematoma | Post Operative Bleeding
Kaohsiung Veterans General Hospital.

Completed

Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

Peptic Ulcer

Taiwan
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions (PLATINUM)

Coronary Artery Disease

United States, Denmark, Australia, Germany, Belgium, Finland, Netherlands, New Zealand, France, United Kingdom, Malaysia, Japan, Singapore, Poland, Latvia, Austria, Portugal
Boston Scientific Corporation

Completed

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) (PLATINUM PK)

Coronary Artery Disease

United States, Japan
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) (PLATINUM LL)

Coronary Artery Disease

United States, Australia, Latvia, Belgium, France, New Zealand, Japan
Kaohsiung Veterans General Hospital.

Completed

Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

Peptic Ulcer

Taiwan
Daiichi Sankyo, Inc.

Completed

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Coronary Artery Disease

United States
Daiichi Sankyo, Inc.
Eli Lilly and Company

Completed

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease (SWAP-2)

Coronary Artery Disease

United Kingdom, United States
Icahn School of Medicine at Mount Sinai

Completed

Aspirin Resistance and Percutaneous Coronary Intervention (PCI) (RESIST)

Stable Angina

United States
Jules Desmeules

Terminated

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Hiv

Switzerland
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
University of California, Davis

Completed

Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease

Peripheral Arterial Disease | Clopidogrel, Poor Metabolism of

United States
Associations for Establishment of Evidence in Interventions

Completed

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Coronary Artery Disease

Japan
Incheon St.Mary's Hospital

Unknown

Polypectomy in Patients Taking Dual Antiplatelet Agents

Colonic Polyps

Korea, Republic of
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
Stiftung Institut fuer Herzinfarktforschung
Daiichi Sankyo, Inc.

Completed

Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI (ETAMI)

Myocardial Infarction | STEMI

France, Germany
AstraZeneca

Completed

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout

Sweden
Medtronic Vascular

Completed

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events (EDUCATE)

Coronary Artery Disease

United States
Takeshi Morimoto

Completed

Short and Optimal Duration of Dual Antiplatelet Therapy Study (STOPDAPT)

Coronary Artery Disease

Japan
Biotronik France
European Cardiovascular Research Center; Allies in Cardiovascular Trials Initiatives...

Completed

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment (GIANT)

Coronary Artery Disease | Acute Coronary Syndrome | Genetic Resistance to Clopidogrel | Compliance to Thienopyridine Treatment

France
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

Myocardial Infarction | Myocardial Ischemia | Acute Coronary Syndrome | Unstable Angina

United States, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, India, Malaysia, Romania, Russian Federation, Serbia, Turkey, Korea, Republic of, ... and more
Kumamoto University

Completed

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study (CALDERA-PCI)

Stable Angina

Japan
Medstar Health Research Institute

Unknown

Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population (VASP)

Increased Drug Resistance

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome (GAMMA)

Acute Coronary Syndrome

France
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)

Acute Coronary Syndrome
Medstar Health Research Institute

Completed

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine (PLACID)

Bleeding | Platelet Aggregation

United States
Medical University of Vienna

Completed

The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation

Sepsis | Healthy Volunteers

Austria

Search clinical trials for: Thienopyridine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations